Latest News
There are more chipmakers to consider in addition to Nvidia.
Via The Motley Fool · March 17, 2026
"Forever" is a long time. Just make sure your picks' underlying companies are capable of lasting that long.
Via The Motley Fool · March 17, 2026

Buying the dip on these two cryptocurrencies has worked before. 2026 should be no different.
Via The Motley Fool · March 17, 2026

Rules surrounding Medicare are not complicated, but it's important to know what to expect.
Via The Motley Fool · March 17, 2026
Via Talk Markets · March 17, 2026
Allison Transmission Holdings (NYSE:ALSN): A Quality Dividend Stock with Strong Fundamentalschartmill.com
Via Chartmill · March 17, 2026
Via Talk Markets · March 17, 2026
One variable has historically been the difference between "magnificent" and "mediocre" for Wall Street's benchmark index.
Via The Motley Fool · March 17, 2026
Plug Power stock rose 4% last week versus a 3% decline for the S&P 500.
Via The Motley Fool · March 17, 2026
These two stocks could be an excellent way to invest in quantum computing while setting yourself up for near-term success as well.
Via The Motley Fool · March 17, 2026
SSR Mining Inc (NASDAQ:SSRM) Passes Key Growth Stock Screen Based on Navellier's "Little Book" Ruleschartmill.com
Via Chartmill · March 17, 2026
Value Investing Opportunity: NATIONAL FUEL GAS CO (NYSE:NFG) Offers a Margin of Safetychartmill.com
Via Chartmill · March 17, 2026
Via Talk Markets · March 17, 2026
Citi's point-sharing feature is disappearing soon. Learn what the change means for cardholders, and what you may want to do before that happens.
Via The Motley Fool · March 17, 2026
Via MarketBeat · March 17, 2026
The Oracle of Omaha's patient stock-picking approach is likely to never go out of style.
Via The Motley Fool · March 17, 2026
The FDA's embattled vaccine chief, Vinay Prasad, will exit the agency. But that doesn't mean biotechs should breathe easy.
Via Investor's Business Daily · March 17, 2026
Via Talk Markets · March 17, 2026
The NCCN updated its 2026 bladder cancer guidelines to include ANKTIVA for more patients. This move broadens its potential use, though the indication is still not FDA-approved.
Via Stocktwits · March 17, 2026
Only the best dividend stocks can achieve "king" status.
Via The Motley Fool · March 17, 2026
TMC The Metals Company could commercialize its deep-sea ambitions soon. But is the start-up worth a $500 investment at this point?
Via The Motley Fool · March 17, 2026
The company’s EP-104GI showed remission rates of 59% at 12 weeks and up to 76% at 24 weeks.
Via Stocktwits · March 17, 2026
The upcoming X Money account may offer 6% APY. Here's what we know so far, plus two high-yield savings accounts paying 4%-plus that you can open today.
Via The Motley Fool · March 17, 2026
You don't need to spend hours researching stocks to build a nest egg.
Via The Motley Fool · March 17, 2026